-
Piracy attacks off Somalia surge in 2026: AFP analysis of IMO data
-
Two killed, one arrested, at school near Berlin: police
-
Tottenham land Marmoush from Manchester City
-
Cox defies Pakistan after Abbas's treble strike rocks England
-
YZi Labs Backs TermMax to Advance On-Chain Bond Market Infrastructure
-
Bosnian Serb war criminal Ratko Mladic dead
-
Nvidia boosts tech stocks but caution dominates ahead of Fed speech
-
Ogura to miss Aragon MotoGP after hand surgery
-
Pogacar holds off Mas to claim Vuelta stage six victory
-
Severe Thunderstorms Hit Eastern Australia After SA Deluge
-
A lasting Dolly Parton legacy: childhood literacy
-
More than goals: What Mourinho wants from Real Madrid's Mbappe
-
S.Africa sounds alarm as infant vaccinations plummet
-
Finland defends shores against oil spill risk
-
Toulouse have salary cap fine reduced on appeal
-
Iraola hoping for 'good news soon' in Liverpool pursuit of Barcola
-
Tech stocks lifted by Nvidia but caution dominates ahead of Fed speech
-
Iran executes over 500 people in 2026: rights group
-
'Smart cricketer' Dinusha helps Sri Lanka draw second India Test
-
Srebrenica: Massacre that outraged the world
-
Zambia opposition leader surrenders to police: state media
-
After US settlement, EU says Meta must 'protect our kids too'
-
Alleged 9/11 mastermind to go on trial in June 2028
-
Germany-led 'frugal' EU states demand budget plan cuts of 'several hundred billion'
-
Abbas's treble strike rocks England in second Test
-
Ratko Mladic: Serb crusader dubbed 'epitome of evil'
-
'Butcher of Bosnia' Ratko Mladic dead: Serbian state media
-
Pramac Yamaha replace Miller with Guevara for 2027 MotoGP season
-
New Zealand make three changes for second South Africa Test
-
Bouaddi needs time at Man City despite 100m euro fee, says Maresca
-
Stocktwits Expands CME Group Alliance with the Integration of Single Stock Futures Data
-
MEXC Launches SHEIN Subscription with $1M Quota as Inaugural IPO Express Event
-
'Mature' Colapinto extends contact with Alpine through 2027
-
Iran, Qatar hold Hormuz talks as US blockade chokes Iran oil imports
-
Atletico rule out any talks with Barcelona over Alvarez
-
Defiant Dinusha helps Sri Lanka draw second India Test
-
Tech stocks lifted by Nvidia as broader markets struggle
-
Pakistan bowl against England in rain-delayed second Test
-
Delap joins Nottingham Forest in club-record deal
-
Barcola move from PSG to Liverpool 'on track': source
-
ICC President Akane Warns U.S. Sanctions Threaten Court's Future
-
Swallowed by silt: Survivors recount Nepal flood horror
-
Delays in Cancer Radiotherapy and Surgery Target Times
-
Germany's Merz hosts 'frugal' leaders ahead of EU budget battle
-
Acrid stench, charred walls reveal devastation of Pakistan infant ward fire
-
Barca sign Croatia goalkeeper Livakovic
-
Norway holds its breath as King Harald's health deteriorates
-
Rain delays England's bid to put off-field incidents behind them
-
Germany reports record 15,800 heat-related deaths this summer
-
World record holder Sawe withdraws from Berlin Marathon
Tenon Medical, Inc. Sets Date for Fourth Quarter and Full Year 2025 Earnings, Reaffirms Expected Revenues
Fourth Quarter 2025 Revenue of $1.45 to $1.48 Million, representing growth of ~90% year over year
Full Year 2025 Revenue of $3.91 to $3.94 Million, representing growth of ~20% year over year
LOS GATOS, CA / ACCESS Newswire / February 5, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company redefining care for patients suffering from sacro-pelvic disorders, today announced plans to release financial results for the fourth quarter and full year 2025 ended December 31, 2025 after market close on Thursday, March 19, 2026. The Company will also hold a conference call on the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with its covering analysts.
Date: | Thursday, March 19, 2026 |
Time: | 4:30 p.m. Eastern time |
Dial-in: | 1-877-407-0792 |
International Dial-in: | 1-201-689-8263 |
Webcast: |
Please dial in at least 10 minutes before the start of the call to ensure timely participation.
An audio playback of the call will be available through April 2, 2026, on Tenon's Investor Relations website at http://ir.tenonmed.com/ or via telephone replay by dialing 1-844-512-2921 (USA) or 1-412-317-6671 (International). The access code will be 13758268.
About Tenon Medical, Inc.

Tenon Medical, Inc., a medical device company formed in 2012, has developed The Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. Since the national launch of the Catamaran SI Joint Fusion System in October 2022, Tenon is focused on three commercial opportunities with its System in the SI Joint market which include: 1) Primary SI Joint procedures, 2) Revision procedures of failed SI Joint implants and 3) Augmenting spinal fusion. For more information, please visit www.tenonmed.com.
The Tenon Medical logo shown above, and Catamaran®, PiSIF®, CAT PiSIF®, ETAD®, Posterior Inferior Sacroiliac Fusion®, CAT SIJ Fusion System®, Catamaran SIJ Fusion System®, Catamaran Inferior Posterior Fusion System®, Catamaran Transfixation Fusion System®, Catamaran Transfixation Fusion Device®, SImmetry® are registered trademarks of Tenon Medical, Inc. MAINSAILTM, and SImmetry+ are also trademarks of Tenon Medical, Inc.
Investor Contact
Shannon Devine
MZ North America
203-741-8811
[email protected]
SOURCE: Tenon Medical, Inc.
View the original press release on ACCESS Newswire
J.Gomez--AT